SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-126852
Filing Date
2023-04-28
Accepted
2023-04-28 16:01:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d420657ddefa14a.htm DEFA14A 11307
2 GRAPHIC g420657g33a01.jpg GRAPHIC 198828
3 GRAPHIC g420657g33a02.jpg GRAPHIC 40911
  Complete submission text file 0001193125-23-126852.txt   330956
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39634 | Film No.: 23865735
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences